We have shown that celastrol inhibits both interleukin (IL)-1β and tumour necrosis factor (TNF), which play an important role since the early phase of RA [18], and has significant anti-inflammatory and anti-proliferative properties in an adjuvant-induced rat model of arthritis (AIA) [17]. This evidence concerns the gene IL1B and arthritic joint disease.